{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:58Z","timestamp":1792790518764,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A19834"],"award-info":[{"award-number":["A19834"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214461\/Z\/18\/Z"],"award-info":[{"award-number":["214461\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["K12CA076917"],"award-info":[{"award-number":["K12CA076917"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00vkwep27","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA202958-01"],"award-info":[{"award-number":["U01CA202958-01"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00vkwep27","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012893","name":"U.S. Department of Health & Human Services | NIH | Division of Loan Repayment","doi-asserted-by":"publisher","award":["P30CA043703"],"award-info":[{"award-number":["P30CA043703"]}],"id":[{"id":"10.13039\/100012893","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","id":[{"id":"https:\/\/ror.org\/00vkwep27","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,11,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumour hypoxia is associated with metastatic disease, and while there have been many mechanisms proposed for why tumour hypoxia is associated with metastatic disease, it remains unclear whether one precise mechanism is the key reason or several in concert. Somatic evolution drives cancer progression and treatment resistance, fuelled not only by genetic and epigenetic mutation but also by selection from interactions between tumour cells, normal cells and physical micro-environment. Ecological habitats influence evolutionary dynamics, but the impact on tempo of evolution is less clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We explored this complex dialogue with a combined clinical\u2013theoretical approach by simulating a proliferative hierarchy under heterogeneous oxygen availability with an agent-based model. Predictions were compared against histology samples taken from glioblastoma patients, stained to elucidate areas of necrosis and\n                      <jats:italic>TP53<\/jats:italic>\n                      expression heterogeneity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results indicate that cell division in hypoxic environments is effectively upregulated, with low-oxygen niches providing avenues for tumour cells to spread. Analysis of human data indicates that cell division is not decreased under hypoxia, consistent with our results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that hypoxia could be a crucible that effectively warps evolutionary velocity, making key mutations more likely. Thus, key tumour ecological niches such as hypoxic regions may alter the evolutionary tempo, driving mutations fuelling tumour heterogeneity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-020-1021-5","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T20:02:21Z","timestamp":1598472141000},"page":"1562-1569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Evidence for hypoxia increasing the tempo of evolution in glioblastoma"],"prefix":"10.1038","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-3278","authenticated-orcid":false,"given":"David Robert","family":"Grimes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnix","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob G.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Basanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"1021_CR1","first-page":"139","volume":"1867","author":"J Scott","year":"2017","unstructured":"Scott, J. & Marusyk, A. Somatic clonal evolution: a selection-centric perspective. Biochim. Biophys. Acta 1867, 139\u2013150 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"1021_CR2","doi-asserted-by":"crossref","first-page":"20130020","DOI":"10.1098\/rsfs.2013.0020","volume":"3","author":"D Basanta","year":"2013","unstructured":"Basanta, D. & Anderson, A. R. Exploiting ecological principles to better understand cancer progression and treatment. Interface Focus 3, 20130020 (2013).","journal-title":"Interface Focus"},{"key":"1021_CR3","doi-asserted-by":"crossref","unstructured":"Prabhu, A., Kesarwani, P., Kant, S., Graham, S. F. & Chinnaiyan, P. Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis. Neuro-oncology 19, 1599\u20131606 (2017).","DOI":"10.1093\/neuonc\/nox100"},{"key":"1021_CR4","doi-asserted-by":"crossref","first-page":"20160939","DOI":"10.1259\/bjr.20160939","volume":"90","author":"DR Grimes","year":"2017","unstructured":"Grimes, D. R., Warren, D. & Warren, S. Hypoxia imaging and radiotherapy: bridging the resolution gap. Br. J. Radiogr. 90, 20160939 (2017).","journal-title":"Br. J. Radiogr."},{"key":"1021_CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker, H. E., Paget, J. T., Khan, A. A. & Harrington, K. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1021_CR6","doi-asserted-by":"crossref","first-page":"45209","DOI":"10.1088\/2057-1976\/1\/4\/045209","volume":"1","author":"DR Grimes","year":"2015","unstructured":"Grimes, D. R. & Partridge, M. A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio. Biomed. Phys. Eng. Express 1, 45209 (2015).","journal-title":"Biomed. Phys. Eng. Express"},{"key":"1021_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10555-007-9062-2","volume":"26","author":"R Sullivan","year":"2007","unstructured":"Sullivan, R. & Graham, C. H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 26, 319\u2013331 (2007).","journal-title":"Cancer Metastasis Rev."},{"key":"1021_CR8","doi-asserted-by":"crossref","unstructured":"Rankin, E. B., Nam, J. M. & Giaccia, A. J. Hypoxia: signaling the metastatic cascade. Trends Cancer 2, 295\u2013304 (2016).","DOI":"10.1016\/j.trecan.2016.05.006"},{"key":"1021_CR9","doi-asserted-by":"crossref","first-page":"20160070","DOI":"10.1098\/rsif.2016.0070","volume":"13","author":"DR Grimes","year":"2016","unstructured":"Grimes, D. R. et al. Estimating oxygen distribution from vasculature in three-dimensional tumour tissue. J. R. Soc. Interface 13, 20160070 (2016).","journal-title":"J. R. Soc. Interface"},{"key":"1021_CR10","doi-asserted-by":"crossref","first-page":"20180256","DOI":"10.1098\/rsif.2018.0256","volume":"15","author":"DR Grimes","year":"2018","unstructured":"Grimes, D. R. & Currell, F. J. Oxygen diffusion in ellipsoidal tumour spheroids. J. R. Soc. Interface 15, 20180256 (2018).","journal-title":"J. R. Soc. Interface"},{"key":"1021_CR11","doi-asserted-by":"crossref","first-page":"e1004712","DOI":"10.1371\/journal.pcbi.1004712","volume":"12","author":"J Scott","year":"2016","unstructured":"Scott, J., Fletcher, A., Anderson, A. & Maini, P. Spatial metrics of tumour vascular organisation predict radiation efficacy in a computational model. PLoS Comput. Biol. 12, e1004712 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"1021_CR12","doi-asserted-by":"crossref","unstructured":"Grogan, J. A. et al. Predicting the influence of microvascular structure on tumour response to radiotherapy. IEEE Trans. Biomed. Eng. 64, 504\u2013511 (2016).","DOI":"10.1109\/TBME.2016.2606563"},{"key":"1021_CR13","doi-asserted-by":"crossref","first-page":"e0161239","DOI":"10.1371\/journal.pone.0161239","volume":"11","author":"A Gomes","year":"2016","unstructured":"Gomes, A. et al. Oxygen partial pressure is a rate-limiting parameter for cell proliferation in 3d spheroids grown in physioxic culture condition. PLoS ONE 11, e0161239 (2016).","journal-title":"PLoS ONE"},{"key":"1021_CR14","doi-asserted-by":"crossref","unstructured":"Leek, R., Grimes, D. R., Harris, A. L. & McIntyre, A. Methods: using three-dimensional culture (spheroids) as an in vitro model of tumour hypoxia. In Tumor Microenvironment, (Koumenis, C., Coussens, L. M., Giaccia, A. & Hammond, E. eds) 167\u2013196 (Springer, Cham., 2016).","DOI":"10.1007\/978-3-319-26666-4_10"},{"key":"1021_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc2329","volume":"8","author":"AR Anderson","year":"2008","unstructured":"Anderson, A. R. & Quaranta, V. Integrative mathematical oncology. Nat. Rev. Cancer 8, 227 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1021_CR16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrc4029","volume":"15","author":"PM Altrock","year":"2015","unstructured":"Altrock, P. M., Liu, L. L. & Michor, F. The mathematics of cancer: integrating quantitative models. Nat. Rev. Cancer 15, 730 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1021_CR17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1006\/bulm.1998.0042","volume":"60","author":"AR Anderson","year":"1998","unstructured":"Anderson, A. R. & Chaplain, M. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60, 857\u2013899 (1998).","journal-title":"Bull. Math. Biol."},{"key":"1021_CR18","doi-asserted-by":"crossref","first-page":"e1003433","DOI":"10.1371\/journal.pcbi.1003433","volume":"10","author":"JG Scott","year":"2014","unstructured":"Scott, J. G., Hjelmeland, A. B., Chinnaiyan, P., Anderson, A. R. & Basanta, D. Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity. PLoS Comput. Biol. 10, e1003433 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"1021_CR19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/0008-5472.CAN-15-2069","volume":"76","author":"B Werner","year":"2016","unstructured":"Werner, B. et al. The cancer stem cell fraction in hierarchically organized tumors can be estimated using mathematical modeling and patient-specific treatment trajectories. Cancer Res. 76, 1705\u20131713 (2016).","journal-title":"Cancer Res."},{"key":"1021_CR20","first-page":"4477","volume":"53","author":"JO Boyle","year":"1993","unstructured":"Boyle, J. O. et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 53, 4477\u20134480 (1993).","journal-title":"Cancer Res."},{"key":"1021_CR21","first-page":"4090","volume":"51","author":"TA Lehman","year":"1991","unstructured":"Lehman, T. A. et al. P53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51, 4090\u20134096 (1991).","journal-title":"Cancer Res."},{"key":"1021_CR22","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1073\/pnas.87.19.7555","volume":"87","author":"NR Rodrigues","year":"1990","unstructured":"Rodrigues, N. R. et al. P53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA 87, 7555\u20137559 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1021_CR23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/0959-8049(95)00399-4","volume":"31","author":"S Thorlacius","year":"1995","unstructured":"Thorlacius, S. et al. Tp53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis. Eur. J. Cancer 31, 1856\u20131861 (1995).","journal-title":"Eur. J. Cancer"},{"key":"1021_CR24","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","volume":"24","author":"A Yemelyanova","year":"2011","unstructured":"Yemelyanova, A. et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for tp53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod. Pathol. 24, 1248 (2011).","journal-title":"Mod. Pathol."},{"key":"1021_CR25","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1158\/0008-5472.CAN-15-3283-T","volume":"77","author":"CD McFarland","year":"2017","unstructured":"McFarland, C. D. et al. The damaging effect of passenger mutations on cancer progression. Cancer Res. 77, 4763\u20134772 (2017).","journal-title":"Cancer Res."},{"key":"1021_CR26","doi-asserted-by":"crossref","first-page":"20130074","DOI":"10.1098\/rsfs.2013.0074","volume":"4","author":"G Yao","year":"2014","unstructured":"Yao, G. Modelling mammalian cellular quiescence. Interface Focus 4, 20130074 (2014).","journal-title":"Interface Focus"},{"key":"1021_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1172\/JCI200420663","volume":"113","author":"I Ben-Porath","year":"2004","unstructured":"Ben-Porath, I. & Weinberg, R. A. When cells get stressed: an integrative view of cellular senescence. J. Clin. Investig. 113, 8\u201313 (2004).","journal-title":"J. Clin. Investig."},{"key":"1021_CR28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/1541-7786.MCR-11-0065","volume":"9","author":"SM Welford","year":"2011","unstructured":"Welford, S. M. & Giaccia, A. J. Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol. Cancer Res. 9, 538\u2013544 (2011).","journal-title":"Mol. Cancer Res."},{"key":"1021_CR29","first-page":"4372","volume":"60","author":"J Yuan","year":"2000","unstructured":"Yuan, J., Narayanan, L., Rockwell, S. & Glazer, P. M. Diminished dna repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low ph. Cancer Res. 60, 4372\u20134376 (2000).","journal-title":"Cancer Res."},{"key":"1021_CR30","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-09-2115","volume":"69","author":"H Enderling","year":"2009","unstructured":"Enderling, H. et al. Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res. 69, 8814\u20138821 (2009).","journal-title":"Cancer Res."},{"key":"1021_CR31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/ng.3891","volume":"49","author":"R Sun","year":"2017","unstructured":"Sun, R. et al. Between-region genetic divergence reflects the mode and tempo of tumor evolution. Nat. Genet. 49, 1015 (2017).","journal-title":"Nat. Genet."},{"key":"1021_CR32","doi-asserted-by":"crossref","unstructured":"Kaznatcheev, A., Scott, J. G. & Basanta, D. Edge effects in game-theoretic dynamics of spatially structured tumours. J. R. Soc. Interface 12, 20150154 (2015).","DOI":"10.1098\/rsif.2015.0154"},{"key":"1021_CR33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","volume":"65","author":"Y Rong","year":"2006","unstructured":"Rong, Y., Durden, D. L., Van Meir, E. G. & Brat, D. J. \u2018Pseudopalisading\u2019 necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J. Neuropathol. Exp. Neurol. 65, 529\u2013539 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1021_CR34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"1021_CR35","doi-asserted-by":"crossref","DOI":"10.1186\/2041-9414-4-5","volume":"4","author":"KR Luoto","year":"2013","unstructured":"Luoto, K. R., Kumareswaran, R. & Bristow, R. G. Tumor hypoxia as a driving force in genetic instability. Genome Integr. 4, 5 (2013).","journal-title":"Genome Integr."},{"key":"1021_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1447-0756.2010.01377.x","volume":"37","author":"M Koi","year":"2011","unstructured":"Koi, M. & Boland, C. R. Tumor hypoxia and genetic alterations in sporadic cancers. J. Obstet. Gynaecol. Res. 37, 85\u201398 (2011).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"1021_CR37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ar.21086","volume":"293","author":"W-X Peng","year":"2010","unstructured":"Peng, W.-X. et al. Hypoxia stabilizes microtubule networks and decreases tumor cell chemosensitivity to anticancer drugs through egr-1. Anat. Rec. 293, 414\u2013420 (2010).","journal-title":"Anat. Rec."},{"key":"1021_CR38","doi-asserted-by":"crossref","first-page":"C775","DOI":"10.1152\/ajpcell.00279.2015","volume":"309","author":"ME Hubbi","year":"2015","unstructured":"Hubbi, M. E. & Semenza, G. L. Regulation of cell proliferation by hypoxia-inducible factors. Am. J. Physiol. Cell Physiol. 309, C775\u2013C782 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1021_CR39","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1038\/oncsis.2015.50","volume":"5","author":"K Eales","year":"2016","unstructured":"Eales, K., Hollinshead, K. & Tennant, D. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis 5, e190\u2013e190 (2016).","journal-title":"Oncogenesis"},{"key":"1021_CR40","first-page":"1","volume":"11","author":"DR Grimes","year":"2016","unstructured":"Grimes, D. R. et al. The role of oxygen in avascular tumor growth. PLoS ONE 11, 1\u201319 (2016).","journal-title":"PLoS ONE"},{"key":"1021_CR41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730\u2013737 (1997).","journal-title":"Nat. Med."},{"key":"1021_CR42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.1224676","volume":"337","author":"A Schepers","year":"2012","unstructured":"Schepers, A. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730\u20135 (2012).","journal-title":"Science"},{"key":"1021_CR43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"S Singh","year":"2004","unstructured":"Singh, S., Hawkins, C., Clarke, I. & Squire, J. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"1021_CR44","doi-asserted-by":"crossref","unstructured":"Lan, X. et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. Nature 549, 227\u2013232 (2017).","DOI":"10.1038\/nature23666"},{"key":"1021_CR45","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M., Benito-Hernandez, A., Morrison, S. & Clarke, M. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983\u20138 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1021_CR46","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/stem.1193","volume":"30","author":"Y Luo","year":"2012","unstructured":"Luo, Y. et al. Aldh1a isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells 30, 2100\u201313 (2012).","journal-title":"Stem Cells"},{"key":"1021_CR47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11538-019-00677-y","volume":"82","author":"DR Grimes","year":"2020","unstructured":"Grimes, D. R. & Fletcher, A. G. Close encounters of the cell kind: The impact of contact inhibition on tumour growth and cancer models. Bull. Math. Biol. 82, 20 (2020).","journal-title":"Bull. Math. Biol."},{"key":"1021_CR48","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1038\/cddis.2011.48","volume":"2","author":"A Sermeus","year":"2011","unstructured":"Sermeus, A. & Michiels, C. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis. 2, e164 (2011).","journal-title":"Cell Death Dis."},{"key":"1021_CR49","doi-asserted-by":"publisher","unstructured":"Grimes, D. R., Macauley, R. J., Marnix, J., Scott, J. G. & Basanta, D. Hypoxia increases the tempo of evolution in the peri-necrotic niche in glioblastoma. bioRxiv https:\/\/doi.org\/10.1101\/293712 (2018).","DOI":"10.1101\/293712"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-1021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-1021-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-1021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T19:33:35Z","timestamp":1630006415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-1021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,11,10]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-1021-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for the gathering of the data used in this study was granted by an Advarra Institutional review board at the Moffitt Cancer Center, designation MCC18506, with informed patient consent for all samples analysed. All human data were anonymised, and obtained in accordance with the code of conduct of research of the MCC and the IRB under national and international standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Simulation parameters and details available in the manuscript and Supplementary Material. Further details of the data analysed in this work are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"D.R.G. thanks Cancer Research UK for the travel grant that made this work possible, and the Wellcome trust for their support. We thank the Integrated Mathematical Oncology department at the H. Lee Moffitt Cancer Center and Research Institute. D.R.G. also acknowledges the contributions of NVIDIA research for their generous hardware donations, while D.B. acknowledges the National Institute of Cancer (NCI) for Grant U01CA202958-01 and Florida Health\u2019s Bankhead Coley for 20B06. J.G.S. is grateful to the NIH Loan Repayment programme, the NIH Case Comprehensive Cancer Center (support grant P30CA043703) and the Calabresi Clinical Oncology Research Programme, National Cancer Institute (award number K12CA076917). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}